Conditions of the male breast: Gynaecomastia and male breast cancer (Review)

Molecular Medicine Reports

Volumn 3, Issue 1, 2010, Pages 21-26

  Alali, Laila ^a   Honarpisheh, Helen ^a   Shaaban, Abeer ^b   Speirs, Valerie ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Gynaecomastia; Male breast cancer; Males

Indexed keywords

ANASTROZOLE; FLUOROURACIL; RALOXIFENE; TAMOXIFEN;

ADJUVANT THERAPY; BREAST CANCER; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GYNECOMASTIA; HAIR LOSS; HORMONAL THERAPY; HOT FLUSH; HUMAN; IMPOTENCE; MALE; MALE BREAST; MALE BREAST CANCER; MASTECTOMY; MOOD CHANGE; ORCHIECTOMY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION; SIDE EFFECT; WEIGHT GAIN;

EID: 76149124215     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000213     Document Type: Review

References (61)

1. Peate I: Caring for men with breast cancer: causes, symptoms and treatment. Br J Nurs 10: 975-981, 2001.
2. Kopans DB: The Male Breast in Breast Imaging. 3rd edition, Lippincott Williams & Wilkins, Baltimore, pp671-690, 2006.
3. Wertkin MG: Diagnosis and management of male breast cancer in the community hospital setting (letter to editor). Breast J 12: 188-189, 2006.
4. Fentiman IS, Fourquet A and Hortobagyi GN: Male breast cancer. Lancet 367: 595-604, 2006.
5. Giordano SH, Cohen DS, Buzdar AU, Perkins G and Hortobagyi GN: Breast carcinoma in men: a population-based study. Cancer 103: 432-433, 2005.
6. Williams BG, Iredale R, Brian K, France E, Barrett-Lee P and Gray J: Experience of men with breast cancer: an explanatory focus group study. Br J Cancer 89: 1834-1836, 2003.
7. Rossmann ED, Liljegran A and Bergh J: Male breast cancer - how to treat? Breast Cancer Online 10: e15, 2007.
8. Meguerditchian A, Falardeau M and Martin G: Male breast carcinoma. Can J Surg 45: 296-302, 2002.
9. Nahleh Z and Girnius S: Male breast cancer: a gender issue. Nat Clin Pract Oncol 3: 428-437, 2006.
10. Giordano SH, Buzdar AU and Hortobaghi GN: Breast cancer in men. Ann Intern Med 137: 678-687, 2002.
11. Burga AM, Fadare O, Lininger RA and Tavassoli FA: Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch 449: 507-512, 2006.
12. Pappo I, Wasserman I and Halevy A: Ductal carcinoma in situ of the breast in men: a review. Clin Breast Cancer 6: 310-314, 2005.
13. Girodana SH: A review of the diagnosis and management of male breast cancer. Oncologist 10: 471-479, 2005.
14. Leach IH, Ellis IO and Elston CW: c-erb-B-2 expression in male breast carcinoma. J Clin Pathol 45: 942, 1992.
15. Blin N, Kardas I, Welter C, et al: Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Oncology 50: 408-411, 1993.
16. Bloom KJ, Govil H, Gattuso P, Reddy V and Francescatti D: Status of HER-2 in male and female breast carcinoma. Am J Surg 182: 389-392, 2001.
17. Muir D, Kanthan R and Kanthan SC: Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 127: 36-41, 2003.
18. Dixon JM and Sainsbury JRC: Handbook of Diseases of the Breast. 2nd edition, Churchill and Livingstone, Edinburgh, pp54-56, 1998.
19. Cakan N and Kamat D: Gynecomastia: evaluation and treatment recommendations for primary care providers. Clin Pediat 46: 487-490, 2007.
20. Bembo SA and Carlson HE: Gynaecomastia: its features, and when and how to treat. Cleve Clin J Med 71: 511-517, 2004.
21. Glen D and Braunstein MD: Gynecomastia. N Engl J Med 357: 1229-1237, 2007.
22. Daniels IR and Layer GT: How should gynaecomastia be managed? ANZ J Surg 73: 213-216, 2003.
23. Weiss JR, Moysich KB and Swede H: Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 14: 20-26, 2005.
24. Syrjakoski K, Jantti J, Kallioniemi A and Karhu R: Mutations in the BRCA2 interacting DSS1 are not a risk factor for male breast cancer. Int J Cancer 120: 444-446, 2006.
25. Martin A and Weber BL: Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 92: 1126-1135, 2000.
26. Wooster R, Mangion J, Eeles R, et al: A germline mutation in the androgen receptor gene in 2 brothers with breast cancer and Reifenstein syndrome. Nat Genet 2: 132-134, 1992.
27. Syrjakoski K, Hyytinen ER, Kuukasjarvi T, et al: Androgen receptor gene alterations in Finnish male breast cancer. Breast Cancer Res Treat 77: 167-170, 2003.
28. Tynes T: Electromagnetic fields and male breast cancer Biomed Pharmacother 47: 425-427, 1993.
29. Sorensen HT, Friis S, Olsen JH, et al: Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol 93: 231-233, 1998.
30. Lenfant-Pejovic MH, Mlika-Cabanne N, Bouchardy C and Auquier A: Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer 45: 661-665, 1990.
31. Weiderpass E, Ye W, Adami HO, Vainio H, Trichopoulos D and Nyren O: Breast cancer risk in male alcoholics in Sweden. Cancer Causes Control 12: 661-664, 2001.
32. DepartmentofHealth:PublicHealth.Healthimprovement.Obesity.http://www.dh. gov.uk/en/Publichealth/Healthimprovement/Obesity/index.htm.
33. Wise GJ, Roorda AK and Kalter R: Male breast disease. J Am Coll Surg 200: 255-269, 2005.
34. Gewurz BE, Dezube BJ and Pantanowitz L: HIV and the breast. AIDS Reader 15: 392-396, 2005.
35. Binder G, Iliev DI, Dufke A, et al: Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. J Clin Endocrinol Metab 90: 484-492, 2005.
36. Stratakis CA, Vottero A, Brodie A, et al: The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant p450 aromatase gene transcription. J Clin Endocrinol Metab 83: 1348-1357, 1998.
37. Berkovitz GD, Guerami A, Brown TR, MacDonald PC and Migeon CJ: Familial gynecomastia with increased extraglandular aromatization of plasma carbon 19-steroids. J Clin Invest 75: 1763-1769, 1985.
38. Boughey JC, Bedrosian I, Meric-Bernstam F, et al: Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203: 475-480, 2006.
39. Patterson JS, Battersby LA and Bach BK: Use of tamoxifen in advanced male breast cancer. Cancer Treat Rep 64: 801-804, 1980.
40. Anelli TF, Anelli A, Tran KN, Lebwohl DE and Borgen PI: Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 74: 74-77, 1994.
41. Donegan WL and Redlich PN: Breast cancer in men. Surg Clin North Am 76: 343-363, 1996.
42. Baum M, Budzar AU, Cuzick J, et al; ATAC Trialists' Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359: 2131-2139, 2002.
43. Coombes RC, Hall E, Gibson LJ, et al: Intergroup Exemestane Study. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350: 1081-1092, 2004.
44. Goss PE, Ingle JN, Martino S, et al: A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349: 1793-1802, 2003.
45. Zabolotny BP, Zalai CV and Meterissian SH: Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. J Surg Oncol 90: 26-30, 2005.
46. Arriola E, Hui E, Dowsett M and Smith IE: Aromatase inhibitors and male breast cancer. Clin Transl Oncol 9: 192-194, 2007.
47. Meyskens FL Jr, Tormey DC and Neifeld JP: Male breast cancer: a review. Cancer Treat Rev 3: 83-93, 1976.
48. Jaiyesimi IA, Buzdar AU, Sahin AA and Ross MA: Carcinoma of the male breast. Ann Int Med 117: 771-777, 1992.
49. Giordano SH, Valero V, Buzdar AU and Hortobagyi GN: Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 25: 235-237, 2002.
50. Lawrence SE, Faught KA, Vethamuthu J and Lawson ML: Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 145: 71-76, 2004.
51. Plourde PV, Reiter EO, Jou HC, et al: Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89: 4428-4433, 2004.
52. Iwuagwu OC, Calvey TA, Ilsley D and Drew PJ: Ultrasound guided minimally invasive breast surgery (UMIBS): a superior technique for gynecomastia. Ann Plast Surg 52: 131-133, 2004.
53. Easton DF, Pooley KA, Dunning AM, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093, 2007.
54. Iredale R, Brian K, Williams B, France E and Gray J: The experiences of men with breast cancer in the United Kingdom. Eur J Cancer 42: 334-341, 2006.
55. Brain K, Williams B, Iredale R, France E and Gray J: Psychological distress in men with breast cancer. J Clin Oncol 24: 95-101, 2006.
56. Lazala C and Saenger P: Pubertal gynecomastia. J Pediatr Endocrinol Metab 15: 553-560, 2002.
57. Cavanaugh J, Niewoehner CB and Nuttall FQ: Gynecomastia and cirrhosis of the liver. Arch Intern Med 150: 563-565, 1990.
58. Pawlowski E and Nield LS: Gynecomastia and hypogonadism. Clin Pediatr 47: 313-315, 2008.
59. Venara M, Rey R, Besgadá I, Mendilaharzu H, Campo S and Chemes H: Sertoli cell proliferations of the infantile testis: an intratubular form of Sertoli cell tumor? Am J Surg Pathol 25: 1237-1244, 2001.
60. Zarrilli S, Lombardi G, Paesano L, et al: Hormonal and seminal evaluation of Leydig cell tumour patients before and after orchiectomy. Andrologica 32: 147-154, 2000.
61. Tagawa N, Takano T, Fukata S, et al: Serum concentration of androstenediol and androstenediol sulfate in patients with hyperthyroidism and hypothyroidism. Endocr J 48: 345-354, 2001.